N 894 150
Pill imprint N 894 150 has been identified as Nizatidine 150 mg.
Nizatidine is used in the treatment of gerd; stomach ulcer; indigestion; erosive esophagitis; duodenal ulcer (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy.
Nizatidine 150 mg is not subject to the Controlled Substances Act.
See also related documents.
Nizatidine Images
- Imprint:
-
N 894
150 - Strength:
- 150 mg
- Color:
- Brown & White
- Size:
- 18.00 mm
- Availability:
- Rx and/or OTC
- Inactive Ingredients:
- gelatin
silicon dioxide
sodium starch glycolate type A potato
titanium dioxide
ferric oxide yellow
ferric oxide red
magnesium stearate
sodium lauryl sulfate
magnesium silicate
- Drug Class:
- H2 antagonists
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00093-1065
Advertisement
More Nizatidine resources
- Nizatidine (Wolters Kluwer)
- Nizatidine Solution (Wolters Kluwer)
- nizatidine (Cerner Multum)
- Nizatidine (AHFS DI)
- Nizatidine (FDA)
- Nizatidine Solution (FDA)
- Nizatidine (Wolters Kluwer)
Search Again
